As shares recover, buy VGAC stock ahead of 23andMe Merger.
Looks like a good time to enter VGAC. Gaining volume, MACD reversal, currently oversold on the RSI
NYSE:VGAC Possible Scenario: LONG Evidence: Price Action This is my idea and could be wrong 100%. It's up 30% already, but I expect another 20%, it's risky adjust your position.
Going long the 23andMe SPAC Merger Rumors with a plan to sell the news. At $13.50/share, this has been a decent entry of almost any SPAC. Regardless of news etc. we plan on selling the majority of our positions BEFORE the ticker changes to avoid being over exposed during the warrant execution period and subsequent dilution. From a technical analysis perspective,...